A trial run of over-the-counter sales of emergency contraception, also known as the morning-after pill, started on Nov. 28 at two to six pharmacies in each prefecture of Japan. The number of ...

The drug is Japan's first domestically developed oral drug for patients with mild COVID symptoms. Other pill-based treatments developed by Pfizer Inc. and Merck & Co. were previously approved for ...